LifeMD, Inc. reported significant financial performance for the fiscal year ending December 31, 2025, with total telehealth revenue reaching approximately $194.1 million, marking a 25% increase from $154.8 million in 2024. The company achieved a gross profit of $166.3 million, maintaining a gross margin of 86%. Despite the revenue growth, LifeMD incurred a net loss from continuing operations of $10.2 million, an improvement from the $23.2 million loss reported in the previous year. The overall net income, including discontinued operations, was $15.6 million, a notable turnaround from a net loss of $20.9 million in 2024.

The company experienced several strategic developments during the year, including the sale of its majority interest in WorkSimpli, which was classified as discontinued operations, resulting in a gain of $21.3 million. Additionally, LifeMD expanded its service offerings by acquiring Optimal Human Health MD, enhancing its capabilities in women's health and hormone replacement therapies. The company also began accepting private health insurance for its virtual primary care services, significantly broadening its market reach.

Operationally, LifeMD served approximately 328,000 active patient subscribers by the end of 2025, with a total of 1.39 million patients served since inception. The company’s telehealth subscription model accounted for about 95% of its revenue, reflecting strong customer engagement. LifeMD's patient care center employed 119 individuals, contributing to its operational capacity. The company also reported a significant increase in selling and marketing expenses, which rose by 23% to $86.1 million, aimed at driving sales growth.

Looking ahead, LifeMD anticipates continued growth driven by its investments in technology and marketing, as well as the expansion of its service offerings. The company expects to leverage its proprietary telehealth platform and affiliated provider network to enhance patient experiences and increase market share. However, it also faces challenges, including the need to manage increasing operational costs and navigate a competitive landscape in the telehealth sector. The company’s liquidity position remains strong, with $36.8 million in cash as of December 31, 2025, which it believes will support its operational needs for at least the next 12 months.

About LifeMD, Inc.

LifeMD, Inc. is a telehealth provider delivering virtual and in-home healthcare services across primary care, men's and women's health, weight management, and hair loss. It operates proprietary technology platforms, affiliated provider networks, and a fully integrated pharmacy to offer accessible, cost-effective medical treatments and prescriptions nationwide. The company focuses on subscription-based models, patient retention, and expanding clinical offerings in a competitive digital healthcare market.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-K Filings

A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.

Key points about the 10-K:

  • Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
  • Content: It includes:
    • Detailed financial statements audited by an independent accounting firm
    • Management's Discussion and Analysis (MD&A) of financial condition and results
    • Description of the company's business, properties, and legal proceedings
    • Risk factors and market risks
    • Executive compensation and corporate governance information
  • Importance: Considered the most comprehensive and important document a public company files with the SEC.
  • Length: Often exceeds 100 pages due to its extensive and detailed nature.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.